TrialGynecologic oncology2012

A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal carcinoma: MC0261.

Keith C Bible et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.